Ascribe Bioscience Revenue, Growth & Competitor Profile

DBA ASCRIBE BIOSCIENCE INC

Company Profile & Annual Report for Ascribe Bioscience

Access the complete profile.

Ascribe Bioscience Fast Facts

Revenue	Less than $1 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	95 Brown Rd Ste 202 Ithaca, NY 14850

Note: Revenues for privately held companies are statistical evaluations.


Ascribe Bioscience's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Ascribe Bioscience's annual revenues are Less than $1 million (see exact revenue data)
• What industry is the company in?
  • Ascribe Bioscience is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Ascribe Bioscience Annual Revenue and Growth Rate

Ascribe Bioscience	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	Less than $1 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Ascribe Bioscience's revenues are gauged from an analysis of company filings.

Ascribe Bioscience's Income Statement (based on Industry Averages)

Ascribe Bioscience P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Ascribe Bioscience has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
August 3, 2022	7	97%	$3 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Ascribe Bioscience is developing and marketing. Ascribe Bioscience doesn't have any recent trademark applications, indicating Ascribe Bioscience is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
PRELUDE Biostimulants being plant growth stimulants; Biostimulants being plant nutrition preparations	04/15/2021
PHYTALIX Pesticides for agricultural use	06/29/2019

See all trademarks and details in the Full Report.

Market Share of Ascribe Bioscience's Largest Competitors

A competitive analysis shows these companies are in the same general field as Ascribe Bioscience, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Ascribe Bioscience. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BOYCE THOMPSON INSTITUTE FOR PLANT RESEARCH	Ithaca, NY	100
GRAMMATECH	Ithaca, NY	85
CLINVET USA	Waverly, NY	52
ATC-NY	Trumansburg, NY	48
ADVION	Ithaca, NY	45
IFYBER	Ithaca, NY	20

Future Competition: Ascribe Bioscience's Fastest Growing Competitors

These companies are in the same general field as Ascribe Bioscience and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)